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Abstract Silver nanoparticles are the most important nanomaterials for antibacterial uses
and are famous for their strong inhibitory and antibacterial effects. In recent years,
extensive studies have been undertaken on the use of antimicrobial properties of silver,
incorporated within aquaculture industry. To evaluate the scientific basis for the use of the
nano silver in shrimp aquaculture, in this study the antimicrobial activities of colloidal
nano silver with two different sizes (16.62 and 22.22 nm) was evaluated against gram
negative bacteria, V. harveyi. Before the experiments, cAgNPs were characterized using
several analytical techniques. Well diffusion method, micro-dilution tests (MIC and MBC)
and kinetic of death were used to evaluate the bactericidal activity of the nanoparticles.
Results showed that MIC and MBC values of cAgNPs in both studied sizes are equal
(MIC = MBC). Best bactericidal kinetics in the presence of 16.62 and 22.22 nm
nanoparticles obtained at 4 and 6 h, respectively. The obtained results suggested that
smaller silver nanoparticles had a faster antibacterial activity than the larger particles.
According to the obtained results, the activity of cAgNPs against V. harveyi is fast and has
potential for the treatment of bacterial infection in aquaculture.
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cAgNPs Colloidal silver nanoparticles
CFU Colony-forming unit
DLS Dynamic light scattering
ICP Inductively coupled plasma mass spectroscopy
MBC Minimum bactericidal concentration
MHA Mueller-Hinton agar
MHB Mueller-Hinton broth




ROS Reactive oxygen species
SPR Surface plasmon resonance
TSA Tryptic soy agar
TSB Tryptic soy broth
XRD X-ray diffractometer
ZOI Zone of inhibition
Introduction
In past decades, shrimp culture has developed throughout the world. Over the past decade,
the shrimp industry has been accompanied by the occurrence of serious bacterial diseases
such as vibriosis (especially the luminous V. harveyi) (Khamesipour et al. 2014). V.
harveyi is known as an important causative agent of vibriosis disease in shrimp farms
worldwide, which causes mortalities up to 100 % at a time in shrimp rearing systems
(Ramesh et al. 2014). It is worth noting that Vibrio harveyi is a species of gram negative,
bioluminescent, facultative anaerobic and halophilic bacteria in the genus Vibrio
(Khamesipour et al. 2014; Ramesh et al. 2014). During the recent several years, researchers
have reported that use of antibiotics for controlling disease outbreaks may lead to the
emergence of antibiotic resistance bacteria (Domrongpokkaphan and Wanchaitanawong
2006). One of the alternative methods for controlling resistance of bacteria in treatment of
diseases is the use of nanomaterials such as silver nanoparticles (AgNPs) (Kim et al. 2007;
Petrus et al. 2011). Among the nanoparticles, silver or its compounds have known to have
high antimicrobial and broad spectrum antimicrobial activities for bacteria, fungi and virus
(Cho et al. 2005; Petrus et al. 2011). Compared with the eukaryote cells (or mammalian
cells), AgNPs exhibits higher toxicity to microorganisms (Li et al. 2010). The antimi-
crobial properties of AgNPs are well established, and several mechanisms for their bac-
tericidal effects have been proposed (Sondi and Salopek-Sondi 2004). Recent studies using
silver nanoparticles have demonstrated a broad range of antimicrobial activity against
several gram positive pathogenic bacteria such as Staphylococcus aureus (Kim et al. 2007;
Petrus et al. 2011), B. subtilis (Savithramma et al. 2011) and Lactococcus garvieae (Soltani
et al. 2009), gram negative pathogenic bacteria such as Klebsiella pneumonia (Savi-
thramma et al. 2011), Salmonella typhi (Petrus et al. 2011), V. cholera (Petrus et al. 2011;
Dibrov et al. 2002), V. fischeri (Binaeian et al. 2012), V. harveyi (Vaseeharan et al. 2010),
V. alginolyticus (Vaseeharan et al. 2012), Proteus vulgaris (Savithramma et al. 2011),
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E. coli (Petrus et al. 2011; Li et al. 2010; Savithramma et al. 2011; Kim et al. 2007; Sondi
and Salopek-Sondi 2004), Pseudomonas aeroginosa (Savithramma et al. 2011), Strepto-
coccus iniae (Soltani et al. 2009), Yersinia ruckeri (Soltani et al. 2009), Aeromonas
hydrophila (Sarkar et al. 2012; Soltani et al. 2009), viruses, pathogenic fungi (Johari et al.
2015) and eukaryotic microorganisms (Vaseeharan et al. 2012).
So far, several investigations have described different parameters that influence
antibacterial effects of AgNPs. These factors include properties such as size, shape, surface
chemistry, crystallinity, capping agent and dose of AgNPs (Martı´nez-Castan˜o´n et al. 2008;
Zhang et al. 2014). However, the size of nanoparticles is one of the most important factors
determining antimicrobial potential of AgNPs. Furthermore, the main objective of the
present study was to evaluate the effect of particle size on the antibacterial activity of
AgNPs against Vibrio harveyi. Therefore, the antibacterial activity of AgNPs with two
different sizes (16.62 and 22.22 nm) was assessed by determining the minimal inhibitory
concentration (MIC), the minimum bactericidal concentration (MBC), well diffusion
method and measuring the dynamic growth curve of the bacteria.
Materials and methods
Silver nanoparticles characterization
The colloidal silver nanoparticles (cAgNPs), type L (commercial name: Nanocid), were
prepared from Nano Nasb Pars Co. Ltd., Tehran, Iran. The present research used two sizes
of colloidal silver nanoparticles. The colloid product was synthesized using a novel process
involving the photo-assisted reduction of Ag? to metallic nanoparticles, registered under
United States Patent Application No: 20090013825 (Rahman Nia 2011). Before launching
the experiments, cAgNPs were assayed by different methods: To confirm the presence of
Ag nanoparticles in colloidal solutions, their UV–visible absorption spectra were recorded
using an UV–visible double beam spectrophotometer (UV-1601, Shimadzu, Japan),
between 200 and 800 nm. The crystalline structure of Ag nanoparticles was characterized
using a X-ray diffractometer (Bruker D8 Advance, Bruker AXS, Germany) employing Cu
Ka radiation (k = 1.54 A˚) at 2h ranges from 10 to 80. Average particle sizes and
polydispersity indices (PDI or heterogeneity index) of cAgNPs were measured by a
dynamic light scattering (DLS) technique using Zetasizer Nano ZS90 (Malvern Instru-
ments, Malvern, UK) at 25 C. Concentration of Ag in Ag nanoparticles was determined
with inductively coupled plasma atomic emission spectroscopy (ICP–OES Perkin-Elmer
Optima, 5300 DV, USA).
Microorganism and media
The strain used in this research was luminescence V. harveyi IS01PTTC1755 (NCBI:
GU974342.1), which had been isolated from diseased shrimp of Bushehr province farms,
identified in Iran Scientific and Industrial Research Organization (PTCC: 1755) and doc-
umented in the American Gene Bank (NCBI: GU974342.1).
All culture medium contained Mueller-Hinton Broth (MHB), Mueller-Hinton agar
(MHA), Nutrient broth (NB), Tryptic soy agar (TSA) and Tryptic soy broth (TSB) and
sodium chloride were purchased from Merck (Germany).
Aquacult Int (2017) 25:463–472 465
123
MIC and MBC determination
MICs of the cAgNPs were determined by the serial dilution technique using Mueller-
Hinton broth (supplemented with 2.5 % NaCl) as described by Emmanuel et al. (2015),
with slight modifications. Briefly, about 1 mL of Mueller-Hinton broth medium was added
to 12 test tubes. Final concentrations of the cAgNPs were adjusted between 1/2 in the first
tube and 1/1024 in the tenth tube. Then 1 mL of bacterial suspension containing
1.5 9 108 CFU/mL (0.5 McFarland unit) was added to all tubes and incubated at 30 C for
24 h. After incubation, first dilution with no visible growth was considered as MIC of the
cAgNPs against V. harveyi. Tubes containing nanoparticles and without nanoparticles were
used as controls.
MBC was determined by spread plating 100 lL of all clear tubes (no visible growth) in
the MIC assay on Tryptic soy agar (supplemented with 2.5 % NaCl). Then, plates were
incubated at 30 C for 24 h. After incubation period, the highest dilution which inhibited
colony formation on agar was noted as MBC.
Kinetics study of cAgNPs against Vibrio harveyi
The kinetic study was carried out using protocol of Chatterjee et al. (2011) with minor
modifications. Briefly, 5 % of overnight broth culture of V. harveyi (50 mL with
ODA600 = 0.2 equivalent to 3 9 10
8 CFU/mL) was mixed with fresh nutrient broth
(100 mL) supplemented with AgNPs at dose equivalent to MIC (*4 mg/L). The cultures
were incubated at 30 C with shaking at 150 rpm. The microbial growth was monitored by
measuring the optical density (O.D) at 600 nm at 30-min intervals for 7 h using UV–Vis
Spectrophotometer (6800 Jenway Inc., England).
Zone of inhibition (ZOI) assay
The antibacterial activity of cAgNPs was assayed against Vibrio harveyi by using agar well
diffusion method (Ahmad and Beg 2001). In brief, Mueller-Hinton Agar (MHA) plates
were inoculated uniformly with 1.5 9 108 CFU/mL (0.5 McFarland Standard) of bacterial
suspension, using sterile swabs in triplicates. Wells of 6 mm size were created with sterile
cork borer in the agar plates containing the bacterial inoculum. Then, 50 lL of cAgNPs
was introduced into each of the wells and allowed to diffuse at 4 C for 2 h. Finally, the
plates were incubated at 30 C for 24 h.
Results
Particle characterization of cAgNPs
Silver nanoparticles existence in tow suspensions (cAgNPs) were confirmed using UV–Vis
spectral analysis and both samples showed silver surface plasmon resonance (SPR) band at
420 nm (Fig. 1). The crystalline structure of Ag-NPs in tow colloids was confirmed by
X-ray diffraction analysis as shown in Fig. 2a, b. As shown in Fig. 2, there was no obvious
difference in the XRD patterns between 16.62 and 22.22 nm silver nanoparticles. Four
distinct diffraction peaks were observed for AgNPs at (111), (200) (220) and (311) (Fig. 2).
These peaks are exactly matched with the Joint Committee on Powder Diffraction
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Standards (JCPDS) file No. 04-0783. Particle size distribution and polydispersity index
(PDI) of silver nanoparticles in two colloids were obtained by Dynamic light scattering
(DLS) technique (Fig. 3 a and b). The DLS results indicated that the mean sizes (Z-
average) of nanoparticles were 16.62 and 22.22 nm, and the mean of PDI of the
nanoparticles were 0.23 and 0.21, respectively. The concentrations of Ag nanoparticles
were measured by ICP_OES and were found to be approximately 4000 ppm (in both
colloids).
Determination of MIC and MBC
The results of the MIC and MBC of cAgNPs (with different sizes) against V. harveyi are
shown in Table 1. The MIC and MBC values of both sizes of cAgNPs were equal
(MIC16.6 and 22.22 nm = MBC16.62 and 22.22 nm) (3.91 mg/L). The calculation of MIC/MBC
ratio shows that this value is equal to 1 for V. harveyi (Table 1).
Fig. 2 XRD patterns of AgNPs in colloids: a 16.62, b 22.22 nm
Fig. 1 UV–Vis absorption spectrum of AgNPs in colloids: a 16.62, b 22.22 nm
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Kinetics of antibacterial activity
The study of the effects of cAgNPs on growth kinetics of V. harveyi was done in com-
parison with the normal growth (Fig. 4). A very strong antimicrobial activity was seen by
both cAgNPs. However, the fastest antibacterial activity was seen by 16.62 nm AgNPs. As
shown in Fig. 4, 16.62 nm AgNPs reduced bacterial growth to undetectable levels after 4 h
of contact, whereas in 22.22 nm AgNPs the bacteria were killed after 6 h incubation
(almost all treated bacterial cells were dead).
Well diffusion studies
Besides MIC, MBC and growth kinetics methods, antibacterial activity of cAgNPs was
assessed using the well diffusion technique. The both cAgNPs exhibited excellent inhi-
bitory effects against V. harveyi (Fig. 5). And ZOI for sizes of 22.22 and 16.62 nm were
observed 42.1 ± 0.2 mm and 43.12 ± 0.14 mm, respectively. But there was insignificant
difference between antibacterial activities of different sizes of cAgNPs against tested
bacteria (P[ 0.05).
Fig. 3 Dynamic light scattering (DLS) patterns of AgNPs in colloids: a 22.22, b 16.62 nm
Table 1 MIC and MBC indexes of cAgNPs against V. harveyi
Size of cAgNPs (nm) MIC (mg/L) MBC (mg/L) MIC/MBC
22.22 3.91 3.91 1
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Fig. 4 Kinetics of antimicrobial
activities of Ag-NPs against V.
harveyi
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Discussion
In recent times emergence of drug resistance in microbial species (largely bacteria, such as
Vibrio sp.) have become a serious concern in aquaculture industry (Vaseeharan et al.
2012). Therefore, to deal with this challenge (bacterial resistance) new therapeutic
strategies, such as nanoparticles, can be useful. The use of AgNPs as antibacterial agent is
relatively new, and the antibacterial potential of silver nanoparticles has already been
proved by many researchers (Morones et al. 2005; Kim et al. 2007; Sanpui et al. 2008;
Martı´nez-Castan˜o´n et al. 2008; Rai et al. 2009; Lago et al. 2011; Chudobova et al. 2013;
Zhong et al. 2013; Ivask et al. 2014). The aim of present study was to assess the
antibacterial effects of two different sizes of cAgNPs against V. harveyi. The dilution
method results indicated that both sizes of cAgNPs have robust antibacterial activity (see
Table 1), and MIC and MBC values of both size of cAgNPs were equal (MIC = MBC).
Above result strongly showed that cAgNPs has bactericidal properties. Antimicrobial assay
by growth kinetics analysis indicated that cAgNPs with two different sizes had inhibitory
effects against these bacterial cells (Fig. 4). Based on Fig. 4, it can be concluded that
smaller AgNPs are more effective in killing bacteria than larger particles, probably due to
the higher surface area to volume (A/V) ratio in contact with the bacterial cells (Martı´nez-
Castan˜o´n et al. 2008; Lago et al. 2011; Zhong et al. 2013; Ivask et al. 2014). Therefore, the
bactericidal killing properties of AgNPs are size dependent. Results obtained from well
diffusion experiments were also in well agreement with the dilution method results. So that
smaller sized AgNPs showed faster bactericidal activity. Similar results were reported by
Jeong et al. (2014). They demonstrated that 10 nm AgNPs possess higher and faster
cytotoxic and antimicrobial effects compared to 100 nm sized particles against Human
PBMCs and Methylobacterium spp., respectively. Dasgupta et al. (2015) have also
observed that microbial, and cellular toxicology of AgNPs is size dependent. They found
that smaller particles have larger surface area compared to the larger particles. Interest-
ingly, these results agree with those presented by Martı´nez-Castan˜o´n et al. (2008); Lago
et al. (2011); Zhong et al. (2013); Ivask et al. (2014) and Agnihotri et al. (2014). However,
Fig. 5 Comparison of zone of inhibition area caused by 22.22 nm Ag-NPs (a) and 16.6 nm Ag-NPs
(b) against Vibrio harveyi
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it is not wisely only to compare antibacterial efficacy of AgNPs on the basis of size in
different studies, since it will depend on various factors, such as shape, surface chemistry,
crystallinity, capping agent, dose of AgNPs, bacterial strains and composition of culture
media(Hosseinpour Delavar 2014; Nafisi Bahabadi et al. 2016). So mechanism of action of
AgNPs on microbes is only partially understood. There are several antimicrobial mecha-
nisms reported by researchers (Morones et al. 2005; Kim et al. 2007; Sanpui et al. 2008;
Rai et al. 2009; Chudobova et al. 2013). Overall, combinations of mechanisms include: cell
membrane disruption, denaturation of ribosomes, enzymes and proteins inactivation,
depletion of intracellular ATP levels, decrease DNA replication (Feng et al. 2000; Li et al.
2010; Chudobova et al. 2013), formation of free radicals (hydroxyl and ROS), oxidative
stress and inactivating the respiratory chain (Chudobova et al. 2013; Zhang et al. 2014;
Franci et al. 2015). This reveals that more studied are required to evaluate antibacterial
mechanisms of AgNPs on bacterial pathogens in aquatics. Risk assessment studies of
AgNPs in aquatic animals should also be performed before use of this technology in the
aquaculture.
Conclusions
This study reveals that size of AgNPs plays a key role in the antibacterial effects.
Therefore, smaller particles (16.62 nm) showed faster antimicrobial activity than larger
AgNPs (22.22 nm) against luminescent V. harveyi bacteria. Finally, the results of this
study suggest that AgNPs have great potential as antibacterial agents to decrease bacterial
colonization and to overcome the problem of antibiotic-resistant bacteria in aquaculture.
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